He’s talking about 17 otherwise potential placebo patients not being enrolled. He’s been explaining why that’s important to the trial for years. I also found it important when NWBO made the ratio public. I still do. It’s hard to believe any old timers are not aware of Doc Logic’s position on this.
Market Data 
Markets 
AI
